Novel Approach for Clinical Validation of the cobas KRAS Mutation Test in Advanced Colorectal Cancer

2016 
Aim Our objective was to assess the performance of the cobas test versus comparators for KRAS mutation status and predicting clinical response to anti-epidermal growth factor receptor (EGFR) therapy in patients with metastatic colorectal cancer (mCRC).
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    25
    References
    6
    Citations
    NaN
    KQI
    []